Home
>
National Drug Code (NDC)
>
Gemzar
Gemzar - 0002-7501-01 - (Gemcitabine hydrochloride)
Drug Information of Gemzar
| Product NDC: | 0002-7501 |
| Proprietary Name: | Gemzar |
| Non Proprietary Name: | Gemcitabine hydrochloride |
| Active Ingredient(s): | 200 mg/5mL & nbsp; Gemcitabine hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gemzar
| Product NDC: | 0002-7501 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020509 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960522 |
Package Information of Gemzar
| Package NDC: | 0002-7501-01 |
| Package Description: | 5 mL in 1 VIAL (0002-7501-01) |
NDC Information of Gemzar
| NDC Code | 0002-7501-01 |
| Proprietary Name | Gemzar |
| Package Description | 5 mL in 1 VIAL (0002-7501-01) |
| Product NDC | 0002-7501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Gemcitabine hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19960522 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | GEMCITABINE HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
